Disease Modifying Osteoarthritis Drugs: Facing Development Challenges and Choosing Molecular Targets

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|5|528-535

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.5, 2010-05, pp. : 528-535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathways of Inflammatory Activation in Alzheimer's Disease: Potential Targets for Disease Modifying Drugs

By  

Current Medicinal Chemistry, Vol. 9, Iss. 1, 2002-01 ,pp. : 83-88

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and Growth Factors in the Treatment of Osteoarthritis: What Could be the Best Disease Modifying Drugs

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 235-249

Bentham Science Publishers

Access to resources Recommend Favorite

An Update on Disease Modifying Antirheumatic Drugs

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 4, 2014-08 ,pp. : 249-261

Bentham Science Publishers

Access to resources Recommend Favorite

Licofelone a likely disease modifying therapy for osteoarthritis

By  

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Disease-Modifying Therapies for Osteoarthritis: Current Status

By Marc Fajardo   Paul E. Di Cesare  

Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. : 141-161

Adis International

Access to resources Recommend Favorite